OakChart

Harrow Inc

HROWHealthcare·Drug Manufacturers - Specialty & Generic·USA·Small·NASD·Nov 11 • 3:59 PM ET

29.37-0.99 (-3.26%)
2026-11-12 02:24 CET
Market cap
1,138.13 USD m
Revenue, TTM
303.25 USD m
Net income, TTM
-28.49 USD m
Free cash flow, TTM
-20.35 USD m
EPS diluted, TTM
-0.77
P/E
-
Compare

Price

HROW against its 20, 50 and 200-day averages
2050200beatmiss
25.0030.0035.0040.0045.002.7M5.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HROWclose 29.3720-day 28.3950-day 31.15200-day 37.6429.3752w low

46.5% under the 52-week high of 54.85 on 7 Jan 2026. 52-week low 25.76 on 6 Nov 2026. Last 15 sessions, 30.7% high to low

Volume 1.56× normal · the line is the 50-bar volume average

Profile

HROW
52-week range, 12% of the way up
25.7654.85

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company's FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company's ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

IndexRUT
Employees373
IPOApr 24, 2007
Beta0.16
ATR, 14d1.79
Rel volume1.56
Short float22.28%
Insider own15.18%
Inst own57.18%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.10B
Enterprise Value1.33B
Income-28.49M
Sales303.25M
Book/sh0.78
Cash/sh2.01
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees373
IPOApr 24, 2007

Ratios

P/E-
Forward P/E16.42
PEG-
P/S3.64
P/B37.76
P/C14.63
P/FCF-
EV/EBITDA53.55
EV/Sales4.38
Quick Ratio2.12
Current Ratio2.29
Debt/Eq10.31
LT Debt/Eq10.28
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.77
EPS next Y1.79
EPS next Q0.63
EPS this Y-110.95%
EPS next Y705.71%
EPS next 5Y-
EPS past 3/5Y35.17% -1.53%
Sales past 3/5Y45.39% 40.99%
EPS Y/Y TTM-432.41%
Sales Y/Y TTM21.28%
EPS Q/Q866.41%
Sales Q/Q38.61%
EarningsNov 09 AMC
EPS/Sales Surpr.28.60% 0.71%

Ownership

Insider Own15.18%
Insider Trans0.07%
Inst Own57.18%
Inst Trans3.29%
ROA-7.07%
ROE-74.77%
ROIC-8.66%
Gross Margin73.51%
Oper. Margin0.80%
Profit Margin-9.39%
SMA203.44%
SMA50-5.72%
SMA200-21.97%
Trades-

Technical

Shs Outstand37.52M
Shs Float31.84M
Short Float22.28%
Short Ratio11.27
Short Interest7.09M
52W High54.85 -46.45%
52W Low25.76 14.01%
Volatility8.96% 5.61%
ATR (14)1.79
RSI (14)50.43
Beta0.16
Rel Volume1.56
Avg Volume629.35K
Volume979,570

Performance

Perf Week2.16%
Perf Month4.00%
Perf Quarter-24.44%
Perf Half Y-1.53%
Perf YTD-40.06%
Perf Year-24.19%
Perf 3Y129.01%
Perf 5Y163.17%
Perf 10Y1004.14%
Recom1.00
Target Price63.11
Prev Close30.36
Price29.37
Change %-3.26%

Analyst ratings

latest 10 of 11
DateActionAnalystRating changeTargetImplied
Sep 09, 2026InitiatedLLeerink PartnersOutperform$45+53.2%
Jul 11, 2025InitiatedCCantor FitzgeraldOverweight$76+158.8%
Jun 12, 2025InitiatedBBTIG ResearchBuy$62+111.1%
Jun 10, 2025InitiatedWWilliam BlairOutperform
Feb 06, 2025InitiatedHH.C. WainwrightBuy$57+94.1%
Dec 04, 2024ReiteratedRB. Riley SecuritiesBuy$73 → $69+134.9%
Apr 11, 2024InitiatedCCraig HallumBuy$24-18.3%
Sep 08, 2022ResumedRB. Riley SecuritiesBuy$17-42.1%
Oct 14, 2021ResumedRB. Riley SecuritiesBuy$16-45.5%
Sep 24, 2021InitiatedAAegis CapitalBuy$15-48.9%

Peers

Mkt cap
TickerCompanyMkt cap
BLCOBausch + Lomb Corp7.62B
ANIPANI Pharmaceuticals Inc1.63B
TARSTarsus Pharmaceuticals Inc3.78B
OCULOcular Therapeutix Inc1.47B
ALCAlcon Inc34.93B
OCSOculis Holding AG469.78M
EYPTEyePoint Inc30.74M
OTLKOutlook Therapeutics Inc117.10M
ALDXAldeyra Therapeutics Inc39.32M
KPRXKiora Pharmaceuticals Inc5.98M

Insider trading

13 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
AMIR SHOJAEICHIEF SCIENTIFIC OFFICERAug 14 '26Proposed Sale40.0011,250450,000Aug 21 06:32 PM
Shojaei AmirCHIEF SCIENTIFIC OFFICERAug 14 '26Option Exercise35.9611,250404,55011,250Aug 17 05:47 PM
Shojaei AmirCHIEF SCIENTIFIC OFFICERAug 14 '26Sale40.0011,250450,0000Aug 17 05:47 PM
Graves Adrienne LDirectorMay 18 '26Buy31.071,00031,0701,000May 19 07:00 AM
SILVERNAIL LAUREN PDirectorMay 18 '26Buy31.001,00031,0001,000May 19 07:00 AM
BAUM MARK LCHIEF EXECUTIVE OFFICERMay 14 '26Buy30.2010,000302,0002,996,130May 15 07:01 AM
BOLL ANDREW R.PRESIDENT AND CFOMay 14 '26Buy29.903,500104,650814,679May 15 07:00 AM
Opaleye Management Inc.10% OwnerMar 04 '26Sale39.67138,2635,485,18459,428Mar 05 04:05 PM
Opaleye Management Inc.10% OwnerMar 03 '26Sale39.1560,3092,361,24263,691Mar 05 04:05 PM
Opaleye Management Inc.10% OwnerFeb 27 '26Sale54.185,000270,90065,000Mar 03 04:05 PM
Opaleye Management Inc.10% OwnerJan 06 '26Sale53.3520,0001,066,91470,000Jan 08 04:05 PM
BOLL ANDREW R.PRESIDENT AND CFODec 12 '25Option Exercise3.9560,000237,000837,844Dec 16 08:50 PM
BAUM MARK LCHIEF EXECUTIVE OFFICERDec 12 '25Option Exercise3.95180,000711,0003,066,124Dec 16 08:48 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
XPHState Street SPDR S&P Pharmaceuticals ETFAUM: 516.35M
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IHEiShares U.S. Pharmaceuticals ETFAUM: 1.72B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-090.2500.1940.25099.3098.609
2026Q22026-08-10-0.460-0.179-0.46270.6670.358
2026Q12026-05-11-0.740-0.399-0.74144.2052.437
2025Q42026-03-020.1700.3680.17889.0990.008
2025Q32025-11-100.0300.2150.02671.6473.708
2025Q22025-08-110.1300.0080.12963.7466.008
2025Q12025-05-08-0.500-0.046-0.49647.8357.005
2024Q42025-03-270.2400.0820.18966.8361.795
2024Q32024-11-13-0.120-0.053-0.11849.2652.804
2024Q22024-08-07-0.180-0.183-0.18248.9042.513
2024Q12024-05-13-0.380-0.218-0.38234.5936.324
2023Q42024-03-19-0.260-0.043-0.25936.3637.863
2023Q32023-11-13-0.1300.037-0.12834.3037.583
2023Q22023-08-09-0.140-0.040-0.13933.4731.043
2023Q12023-05-11-0.220-0.053-0.21926.1025.133
2022Q42023-03-230.040-0.1170.03620.3321.403

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.100-0.0900.00651.1752.24
2020FY-0.130-0.090-0.13048.8748.74
2021FY-0.690-0.483-0.69172.4871.64
2022FY-0.510-0.670-0.51388.6089.54
2023FY-0.750-0.517-0.748130.19131.69
2024FY-0.490-0.580-0.490199.61194.57
2025FY-0.1400.060-0.140272.3273.82
2026FY--0.295--349.78
2027FY-1.789--525.59
2028FY-3.300--690.51
2029FY-4.950--853.11
2030FY-6.175--975.24

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-10913135.86130.3140.58
2026Q4S2026-11-09902136.29129.12140.99
2026Q4S2026-11-07902136.29129.12140.99
2026Q4S2026-11-02912136.29129.12140.99
2026Q4S2026-10-27921136.84129.12143.2
2026Q4S2026-10-25922136.84129.12143.2
2026Q4S2026-10-12963136.84129.12143.2
2026Q4S2026-09-23963136.18129.12140.99
2026Q4S2026-09-08962136.78130.3140.99
2026Q4S2026-08-24862137.06130.3140.99
2026Q4S2026-08-19862135.56125.54140.99
2026Q4S2026-08-13862135.56125.54140.99
2026Q4S2026-08-11861136.06125.54140.99
2026Q4S2026-07-27801131.19119.21142.91

Estimate history

EPS, annual-0.5980.6140.006-0.13-0.691-0.513-0.748-0.49-0.14-0.7726
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.1180.189-0.4960.1290.0260.178-0.741-0.4620.253
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual26.77441.37251.16548.87172.47688.595130.193199.614272.303303.25
Period201720182019202020212022202320242025TTM
Sales, quarterly49.25766.83147.83163.74271.63889.09244.20370.66199.297
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual20.62324.3425.52725.7526.90329.90235.16835.62237.22937.523
Period201720182019202020212022202320242025MRQ
Shares, quarterly35.61135.62235.65436.71537.03537.22937.26937.48437.523
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue303.25272.30199.61130.1988.5972.4848.8751.1641.37
Cost of Goods Sold Incl. D&A80.3267.9349.2439.6425.3818.2114.4616.7516.52
Gross Profit222.94204.37150.3790.5563.2154.2634.4134.4224.85
Selling, General and Administrative Excl. Other220.51165.76142.0289.9761.3952.5034.3234.6930.07
Research and Development27.5312.8512.956.883.1511.193.072.080.82
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income2.4238.618.350.581.821.760.09-0.28-5.22
Interest Expense23.1524.1822.7921.327.245.442.242.502.73
Unusual Expense3.4516.200.255.840.00-0.960.364.520.39
Net Income Before Taxes-24.19-1.72-18.04-23.94-14.11-17.98-4.07-0.1214.62
Income Taxes4.303.42-0.560.47-0.030.03-0.660.010.00
Consolidated Net Income-28.49-5.14-17.48-24.41-14.09-18.01-3.42-0.1214.62
Net Income From Continuing Operations-28.49-5.14-17.48-24.41-14.09-18.01-3.360.1714.62
Net Income-28.49-5.14-17.48-24.41-14.09-18.48-3.360.1714.62
EPS (Recurring)-0.680.17-0.49-0.62-0.51-0.72-0.120.130.63
EPS (Basic, Before Extraordinaries)-0.77-0.14-0.49-0.75-0.51-0.69-0.130.010.67
EPS (Diluted)-0.77-0.14-0.49-0.75-0.51-0.69-0.130.010.61
EBITDA24.7957.5222.8912.925.484.162.832.39-3.37
Non-Operating Income (Expense)-0.010.05-3.362.65-8.69-15.26-1.577.1822.96
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense12.508.9013.2912.405.813.892.291.072.64
Price To Earnings Ratio--------9.98
Price To Sales Ratio3.916.615.992.814.583.193.634.023.27
Gross Margin73.5175.0575.3369.5571.3574.8770.4167.2660.07
Operating Margin0.8014.184.180.452.052.430.18-0.54-12.61
Net Margin-9.39-1.89-8.76-18.75-15.90-25.50-6.870.3335.35
Shares Outstanding37.5237.2335.6235.1729.9026.9025.7525.5324.34
Market Capitalization1,138.131,138.131,194.87393.32404.63232.44176.62195.85132.45

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue99.3070.6644.2089.0971.6463.7447.8366.83
Cost of Goods Sold Incl. D&A24.3920.3017.1618.4717.7116.2315.5214.13
Gross Profit74.9050.3627.0570.6253.9347.5132.3152.70
Selling, General and Administrative Excl. Other63.4361.3749.1246.5839.1836.1043.5439.54
Research and Development10.298.075.893.273.322.873.034.75
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income11.47-11.01-22.0824.0414.7511.41-11.2313.15
Interest Expense6.216.265.505.196.046.416.556.38
Unusual Expense-5.000.000.008.457.750.000.000.25
Net Income Before Taxes10.26-17.27-27.5810.401.025.00-17.786.26
Income Taxes0.510.000.033.770.000.000.00-0.51
Consolidated Net Income9.76-17.27-27.606.631.025.00-17.786.78
Net Income From Continuing Operations9.76-17.27-27.606.631.025.00-17.786.78
Net Income9.76-17.27-27.606.631.025.00-17.786.78
EPS (Recurring)0.16-0.46-0.740.340.170.13-0.500.19
EPS (Basic, Before Extraordinaries)0.26-0.46-0.740.180.030.14-0.500.19
EPS (Diluted)0.25-0.46-0.740.180.030.13-0.500.19
EBITDA17.49-5.02-16.5028.8219.6416.31-6.3217.96
Non-Operating Income (Expense)0.000.000.00-0.010.06-0.010.00-0.26
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.953.793.032.743.270.883.607.16
Price To Sales Ratio3.915.764.896.707.495.214.486.02
Gross Margin75.4371.2761.1879.2775.2874.5467.5478.85
Operating Margin11.55-15.58-49.9526.9820.5917.90-23.4819.68
Net Margin9.83-24.44-62.447.441.427.84-37.1710.14
Shares Outstanding37.5237.4837.2737.2337.0336.7135.6535.62
Market Capitalization1,101.021,583.071,312.721,814.841,782.761,120.81947.351,194.87

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments72.9347.2582.77101.8650.6732.7630.1528.264.22
Short Term Receivables110.89116.6036.496.394.522.662.011.961.62
Inventories13.5210.7010.876.544.223.963.301.832.25
Other Current Assets14.4015.108.953.471.260.750.590.790.71
Total Current Assets211.75189.65139.07118.2660.6640.1336.0532.848.81
Net Property, Plant & Equipment11.0412.2912.4413.1110.3911.2511.936.386.21
Total Investments and Advances0.000.000.000.0011.133.828.444.953.51
Long-Term Note Receivable-------0.000.30
Intangible Assets176.69187.03160.2424.0616.142.272.675.295.09
Deferred Tax Assets5.73--------
Other Assets0.000.000.001.950.000.000.000.000.00
Total Assets405.21388.97311.75157.3898.3357.4759.0949.4523.92
Short Term Debt Incl. Current Port. of LT Debt0.890.500.810.720.284.492.413.250.60
Accounts Payable35.3538.7621.426.446.343.937.706.253.88
Other Current Liabilities60.0652.0827.1111.473.102.382.172.401.29
Total Current Liabilities96.3091.3449.3418.639.7210.8012.2811.905.77
Long Term Debt251.09228.33189.70111.5177.6819.0518.5812.0014.73
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities5.73--------
Other Liabilities0.000.002.710.000.000.800.800.800.80
Total Liabilities353.12319.67241.75130.1487.4030.6531.6724.7021.30
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity52.4569.6570.3627.5911.2927.1827.7124.752.62
Total Shareholders Equity52.4569.6570.3627.5911.2927.1827.7124.752.62
Accumulated Minority Interest-0.35-0.35-0.35-0.35-0.35-0.35-0.290.000.00
Total Equity52.0969.3070.0027.2410.9326.8327.4224.752.62
Total Liabilities & Stockholders Equity405.21388.97311.75157.3898.3357.4759.0949.4523.92
Book Value Per Share1.411.962.000.920.421.061.091.020.13
Tangible Book Value Per Share-3.34-3.30-2.560.12-0.180.970.980.80-0.12
Full-Time Employees373382315217182125133134128
Price to Book Ratio39.5120.745.19328.3620.606.507.175.609.15
Return on Assets-1.29-4.99-10.41-11.02-23.12-5.760.3139.87-46.85
Return on Equity-8.42-24.97-49.84-72.46-93.62-12.230.64106.88-264.95
Return on Invested Capital-1.69-5.87-9.39-10.13-20.24-7.260.3639.80-69.11
Quick Ratio2.061.962.606.005.813.352.672.611.14
Current Ratio2.202.082.826.356.243.722.932.761.53

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-28.49-5.14-17.48-24.41-14.09-18.01-3.42-0.1214.62
Depreciation21.7918.9114.5412.343.672.402.742.661.84
Other Funds (Non Cash)16.9829.9125.3723.0517.6920.955.840.14-19.22
Funds from Operations10.2743.6822.4210.977.275.335.172.67-2.75
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-29.230.18-44.63-7.13-5.57-0.25-6.27-1.723.44
Cash from Operating Activities-18.9543.86-22.203.841.715.08-1.100.950.69
Capital Expenditures-19.52-1.10-38.67-152.55-7.77-15.92-0.99-1.84-2.20
Net Assets From Acquisitions-4.36-4.360.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.030.000.010.000.00
Purchase or Sale of Investments0.000.005.510.000.009.830.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.005.510.000.009.830.000.000.00
Other Uses0.000.000.000.000.00-12.590.000.000.00
Other Sources0.000.000.000.006.000.000.000.000.00
Cash from Investing Activities-23.87-5.46-33.16-152.55-1.74-18.69-0.98-1.83-2.20
Cash Dividends Paid0.000.000.000.000.00-0.130.000.000.00
Change in Capital Stock1.600.471.1164.9023.30-0.28-0.030.774.88
Repurchase of Common Pref Stock0.000.000.000.000.00-11.000.000.000.00
Sale of Common Pref Stock1.600.471.1164.9023.3010.72-0.030.774.88
Proceedsfrom Stock Options0.000.000.0064.5222.6610.650.000.000.64
Issuance or Reduction of Debt, Net48.3611.8529.7874.6431.7255.101.46-1.77-0.69
Change in Long Term Debt48.3611.8529.7874.6431.7255.101.46-1.77-0.69
Issuance of Long Term Debt48.37242.7529.78134.3931.7471.072.970.000.00
Reduction of Long Term Debt-0.00-230.900.00-59.75-0.02-15.97-1.50-1.77-0.69
Net Financing Active Other Cash Flow-6.09-25.04-2.36-13.01-0.88-3.230.000.00-0.05
Other Financing Activities Uses-6.09-25.04-2.36-13.01-0.88-3.230.000.00-0.05
Cash from Financing Activities43.87-12.7228.53126.5354.1451.471.43-1.014.13
Net Change in Cash1.0525.68-26.84-22.1854.1037.87-0.65-1.892.62
Free Cash Flow-20.3542.98-23.802.38-0.89-10.75-1.96-0.89-1.08
Preferred Dividends (Cash Flow)-0.000.000.000.00-0.130.000.000.00
Price to Free Cash Flow-41.91-153.49-----
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments75.3483.8994.6472.9374.2952.96
Short Term Receivables155.31118.56101.26110.8977.8379.05
Inventories19.2216.9116.5013.5212.8311.55
Other Current Assets11.469.9513.9814.4012.6511.32
Total Current Assets261.33229.31226.38211.75177.60154.89
Net Property, Plant & Equipment10.0110.3510.7211.0411.3511.67
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets171.69177.16182.44176.69174.12178.48
Deferred Tax Assets---5.73--
Other Assets0.000.000.000.000.000.00
Total Assets443.02416.82419.54405.21363.07345.03
Short Term Debt Incl. Current Port. of LT Debt0.890.940.920.890.86184.40
Accounts Payable30.0726.2726.1235.3518.9923.41
Income Tax Payable--2.56---
Other Current Liabilities83.2674.9661.8460.0645.5541.07
Total Current Liabilities114.22102.1791.4496.3065.40248.88
Long Term Debt299.96299.80299.75251.09251.0146.85
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---5.73--
Other Liabilities0.000.000.000.000.000.00
Total Liabilities414.19401.97391.19353.12316.41295.73
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity29.1915.2028.7152.4547.0249.65
Total Shareholders Equity29.1915.2028.7152.4547.0249.65
Accumulated Minority Interest-0.35-0.35-0.35-0.35-0.35-0.35
Total Equity28.8314.8528.3552.0946.6649.30
Total Liabilities & Stockholders Equity443.02416.82419.54405.21363.07345.03
Book Value Per Share0.780.410.771.411.271.35
Tangible Book Value Per Share-3.80-4.32-4.12-3.34-3.43-3.51
Full-Time Employees---373--
Price to Book Ratio37.7655.1425.0338.6035.6219.29
Return on Assets-7.07-9.77-3.82-1.29-1.40-3.14
Return on Equity-74.77-114.80-35.14-8.42-9.54-18.99
Return on Invested Capital2.96-5.48-8.402.180.345.18
Quick Ratio2.122.082.302.062.520.58
Current Ratio2.292.242.482.202.720.62

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income9.76-17.27-27.606.631.025.00
Depreciation6.025.995.584.204.904.90
Other Funds (Non Cash)-0.814.294.299.2212.362.39
Funds from Operations14.96-7.00-17.7320.0418.2712.29
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-23.58-2.768.74-11.63-1.69-13.09
Cash from Operating Activities-8.62-9.76-8.998.4116.59-0.80
Capital Expenditures-0.41-18.53-0.20-0.37-0.23-0.29
Net Assets From Acquisitions0.000.000.00-4.360.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.0018.00-18.000.000.000.00
Purchase of Investments0.0018.00-18.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.41-0.53-18.20-4.73-0.23-0.29
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.580.810.030.180.160.10
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.580.810.030.180.160.10
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.03-0.4448.89-0.0511.890.00
Change in Long Term Debt-0.03-0.4448.89-0.0511.890.00
Issuance of Long Term Debt-0.03-0.4448.89-0.05242.790.00
Reduction of Long Term Debt0.000.000.00-0.00-230.900.00
Net Financing Active Other Cash Flow-0.08-0.830.00-5.18-7.09-12.77
Other Financing Activities Uses-0.08-0.830.00-5.18-7.09-12.77
Cash from Financing Activities0.47-0.4748.91-5.044.96-12.67
Net Change in Cash-8.55-10.7621.72-1.3621.33-13.76
Free Cash Flow-8.99-10.25-9.198.0716.38-0.97
Price to Free Cash Flow-316.2491.8542.45113.02466.80

Revenue breakdown

Other Revenues2024: 995.00K 2025: 394.00K
Product Sales Net2024: 198.62M 2025: 271.91M
United States2024: 199.61M 2025: 272.30M
Branded2024: 116.12M 2025: 195.76M
ImprimisRx2024: 83.50M 2025: 76.55M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3022.30%7.1M31.8M567.35K
2026-10-1523.51%7.5M31.8M584.81K
2026-09-3024.41%7.8M31.8M563.44K
2026-09-1523.55%7.5M31.8M609.61K
2026-08-3121.34%6.8M31.8M653.99K
2026-08-1420.03%6.4M31.8M712.38K
2026-07-3121.60%6.8M31.4M816.71K
2026-07-1521.79%6.8M31.4M816.09K
2026-06-3022.76%7.1M31.4M788.04K
2026-06-1523.27%7.3M31.4M736.83K
2026-05-2921.29%6.7M31.4M875.78K
2026-05-1520.67%6.5M31.4M836.33K
2026-04-3020.86%6.5M31.1M714.00K
2026-04-1520.65%6.4M31.0M702.50K
2026-03-3122.00%6.9M31.2M751.68K
2026-03-1320.03%6.2M31.2M726.79K
2026-02-2717.26%5.4M31.2M553.58K
2026-02-1318.46%5.7M31.0M547.34K
2026-01-3018.39%5.7M31.0M611.21K
2026-01-1517.88%5.5M31.0M617.69K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call17.0010.3014.500.004.7500.000.000.952-0.0630.005
call18.009.6013.2012.453.9052.000.000.948-0.0620.005
call19.008.6012.2011.503.6002.000.000.943-0.0610.005
call20.007.3011.500.003.8380.000.000.937-0.0590.006
call21.006.4010.500.003.4500.000.000.930-0.0580.006
call22.005.409.500.003.2380.000.000.922-0.0560.007
call23.004.408.500.002.8800.000.000.913-0.0540.007
call24.003.407.500.002.5370.000.000.901-0.0510.008
call25.002.556.209.702.1390.000.000.885-0.0480.009
call26.001.455.102.641.82027.000.000.778-0.0920.014
call27.001.254.302.501.69224.0020.000.729-0.0900.015
call28.000.803.502.001.5476.002.000.656-0.0930.017
call29.000.003.304.001.7161.000.000.573-0.1720.018
call30.000.001.201.050.8051507.000.481-0.1070.018
call31.000.001.600.551.01259.002.000.425-0.1230.018
call32.000.002.301.401.1931330.000.364-0.1200.017
call33.000.001.300.251.3551341.000.329-0.1280.017
call34.000.001.250.451.5053.000.000.307-0.1380.016
call35.000.000.300.100.97440326.000.141-0.0570.010
call36.000.002.150.751.0783.000.000.130-0.0590.010
call37.000.002.152.151.17670.003.000.122-0.0620.009
call38.000.002.150.001.2700.000.000.115-0.0640.009
call39.000.002.150.201.3592.000.000.109-0.0660.009
call40.000.000.100.181.4832120.000.103-0.0680.008
call41.000.002.150.101.2084.000.000.047-0.0310.004
call42.000.002.150.001.2760.000.000.045-0.0310.004
call45.000.002.150.001.4680.000.000.040-0.0330.004
put17.000.002.150.002.3780.000.00-0.048-0.0610.005
put18.000.002.150.002.1700.000.00-0.052-0.0600.005
put19.000.002.150.351.97110.000.00-0.057-0.0580.005
put20.000.002.152.401.7824.000.00-0.063-0.0570.006
put21.000.002.150.001.5990.000.00-0.070-0.0550.006
put22.000.002.150.001.4230.000.00-0.078-0.0530.007
put23.000.001.500.951.25216.000.00-0.087-0.0510.007
put24.000.002.150.001.0850.000.00-0.099-0.0490.008
put25.000.000.300.100.92164.000.00-0.115-0.0460.009
put26.000.000.951.031.1728.005.00-0.222-0.0890.014
put27.000.001.454.100.9656.000.00-0.271-0.0870.015
put28.000.000.750.500.75058.005.00-0.343-0.0880.017
put29.000.053.000.751.6599.000.00-0.427-0.1690.018
put30.000.552.801.451.3541025.00-0.519-0.1030.018
put31.000.854.302.301.8454.001.00-0.575-0.1200.018
put32.001.404.902.151.8176.000.00-0.636-0.1170.017
put33.001.855.701.701.7664.000.00-0.682-0.1170.016
put34.002.806.604.701.86710.000.00-0.704-0.1260.016
put35.003.607.707.052.1903.000.00-0.859-0.0530.010
put36.004.708.500.002.2110.000.00-0.870-0.0560.010
put37.005.609.7010.802.4623.000.00-0.878-0.0580.009
put38.006.8010.700.002.5870.000.00-0.885-0.0600.009
put39.007.5011.700.002.7050.000.00-0.891-0.0620.009
put40.008.5012.709.502.8199.000.00-0.951-0.0260.005
put41.009.5013.700.002.9270.000.00-0.953-0.0260.004
put42.0010.5014.700.003.0300.000.00-0.955-0.0270.004
put45.0013.8017.7014.803.3170.000.00-0.960-0.0280.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-06SCHEDULE 13G/ASEC
2026-10-27SCHEDULE 13G/ASEC
2026-10-058-KCurrent report2026-10-01SEC
2026-09-048-KCurrent report2026-09-04SEC
2026-08-21144Filing for proposed sale of securities under Rule 144.SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-08-068-KCurrent report2026-08-03SEC
2026-07-31SCHEDULE 13G/ASEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-228-KCurrent report2026-06-18SEC
2026-06-038-KCurrent report2026-06-03SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-11SCHEDULE 13G/ASEC
2026-05-118-KCurrent report2026-05-11SEC
2026-04-24DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-24DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-12-31SEC
2026-03-278-KCurrent report2026-03-24SEC
2026-03-27SCHEDULE 13G/ASEC
2026-03-248-KCurrent report2026-03-24SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800450.00K1
2026-070000
2026-060000
2026-05468.72K400
2026-040000
2026-03007.85M2
2026-0200270.90K1
2026-01001.07M1
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.7.35%
Opaleye Management Inc.6.44%
Private Capital Management, LLC4.29%
VANGUARD CAPITAL MANAGEMENT LLC3.80%
Deep Track Capital, LP2.60%
STATE STREET CORP2.52%
GEODE CAPITAL MANAGEMENT, LLC2.28%
BAMCO INC /NY/2.17%
DIMENSIONAL FUND ADVISORS LP1.93%
Jupiter Topco LLC1.55%

Funds

Fund% owned
The Osterweis Strategic Income Fund85.56%
Buffalo High Yield Fund37.56%
Catalyst/SMH High Income Fund19.65%
High Yield Bond Series19.15%
Greenspring Income Opportunities Fund16.46%
Fidelity Enhanced High Yield ETF13.90%
iShares Broad USD High Yield Corporate Bond ETF13.58%
Transamerica Multi-Asset Income13.41%
Hotchkis and Wiley High Yield Fund9.99%
Janus Henderson High-Yield Fund8.86%

OakChart. HROW. Cached 15 minutes.